A Prognostic System Applicable to Patients with Resectable Liver Metastasis from Colorectal Carcinoma Staged by Positron Emission Tomography with [18F]Fluoro-2-Deoxy-D-Glucose: Role of Primary Tumor Variables
- 31 May 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 206 (5), 857-868
- https://doi.org/10.1016/j.jamcollsurg.2007.12.023
Abstract
The purpose of this study was to develop a prognostic system applicable to patients with hepatic metastasis from colorectal cancer in whom extrahepatic disease was excluded by preoperative PET with [(18)F]fluoro-2-deoxy-D-glucose (FDG-PET). Data from two institutions were analyzed separately and together to improve general applicability of results. Data were analyzed for 285 consecutive patients undergoing liver resection for colorectal metastases from 1995 to 2005 at 2 institutions routinely using preoperative FDG-PET with. Fifteen clinicopathologic variables of the primary and secondary tumors were examined to identify factors predictive of survival. Outcomes were correlated with poorly differentiated tumor grade in both data sets. Because patients with poorly differentiated tumors comprised a small proportion (16%) of the population, patients with well-differentiated or moderately differentiated tumors were analyzed independently. In this subgroup, positive lymph node status in the primary colorectal tumor resection specimen was the only characteristic that predicted survival of patients in both institutions. Consequently, patients were sorted into three prognostic categories: poor tumor differentiation; well-differentiated or moderately differentiated tumors and node positive; and well-differentiated or moderately differentiated tumors and node negative. These groups had significantly different overall survival on Kaplan-Meier analysis (p=0.0014). In patients with colorectal liver metastases staged with FDG-PET with overall survival can be predicted directly from data in the pathology report of the colorectal primary tumor. This study also indicates the need for new molecular tumor markers of prognosis to complement clinicopathologic markers if the goal of prediction of outcomes in individual patients is to be reached.Keywords
This publication has 40 references indexed in Scilit:
- Hepatic Resection for Colorectal MetastasesAnnals of Surgery, 2007
- Long-Term Characteristics of 5-Year Survivors After Liver Resection for Colorectal MetastasesAnnals of Surgical Oncology, 2007
- Molecular prognostic markers in resectable colorectal liver metastases: A systematic reviewEuropean Journal of Cancer, 2006
- Liver resection for colorectal metastasesThe Annals of The Royal College of Surgeons of England, 2003
- Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring systemJournal of the American College of Surgeons, 1999
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994
- One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinantsBritish Journal of Surgery, 1991
- Treatment of Cancer of the LiverAnnals of Surgery, 1988
- Determinants of survival in liver resection for colorectal secondariesBritish Journal of Surgery, 1986